Skip to main content

Roche’s Pharma Day 2024

The Roche has hosted its Pharma Day 2024 on Monday, 30th September 2024 in London. Please register to access the replay of the webcast.

Agenda
WelcomeBruno Eschli, Head of Investor Relations
GroupThomas Schinecker, CEO Roche Group
PharmaTeresa Graham, CEO Roche Pharmaceuticals
R&D ExcellenceLevi Garraway, EVP, Head Global Product Development and Chief Medical Officer
Oncology/HematologyCharles Fuchs, SVP Global Head of Oncology and Hematology Product Development
NeurologyAzad Bonni, SVP and Global Head of Neurology & Rare Diseases
ImmunologyLarry Tsai, SVP and Global Head of Immunology Product Development
OphthalmologyChristopher Brittain, SVP and Global Head of ophthalmology Product Development
Cardiovascular, Renal and MetabolismManu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism Product Development

Webinar Replay

InvestorsPast IR Events
View more Events

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.